Compare DASH & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DASH | GSK |
|---|---|---|
| Founded | 2013 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.6B | 96.1B |
| IPO Year | 2020 | N/A |
| Metric | DASH | GSK |
|---|---|---|
| Price | $167.75 | $51.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 31 | 2 |
| Target Price | ★ $265.58 | N/A |
| AVG Volume (30 Days) | ★ 4.7M | 4.6M |
| Earning Date | 05-20-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.28% |
| EPS Growth | ★ 634.48 | N/A |
| EPS | ★ 2.13 | N/A |
| Revenue | ★ $13,717,000,000.00 | N/A |
| Revenue This Year | $32.73 | $6.81 |
| Revenue Next Year | $19.78 | $4.74 |
| P/E Ratio | $79.76 | ★ $32.75 |
| Revenue Growth | ★ 27.93 | N/A |
| 52 Week Low | $155.40 | $32.38 |
| 52 Week High | $285.49 | $61.70 |
| Indicator | DASH | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 40.91 | 33.39 |
| Support Level | $158.00 | $47.89 |
| Resistance Level | $188.49 | $60.37 |
| Average True Range (ATR) | 5.80 | 0.97 |
| MACD | 0.43 | -0.71 |
| Stochastic Oscillator | 22.13 | 5.54 |
Founded in 2013 within the confines of the San Francisco application renaissance, DoorDash is an online delivery demand aggregator. Consumers can use its app to order food on demand for delivery or in-store pickup from participating merchants. Following the 2022 acquisition of Wolt, the firm also provides this service in Europe and Asia. DoorDash creates a marketplace for merchants to establish an online presence, market their offerings, and meet demand through delivery. The firm provides similar services to non-restaurant businesses, such as grocery, retail, and pet supplies. DoorDash is also rolling out emerging technologies, such as drone delivery, to continually innovate and deliver the best possible service to both supply-side and demand-side participants in its marketplace.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.